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Background: Epilepsy is a devastating disorder that impacts on patients’ quality of life, irrespective of use of anti
epileptic drugs (AEDs). This study estimates the health-related quality of life (HRQOL) and its associated predictors
among epilepsy patients receiving AEDs.
Methods: A total of 175 epilepsy patients already receiving AED for at least 3 months were randomly selected and
interviewed from mental clinics at Mulago and Butabika national referral hospitals in Uganda between May - July
2011. A HRQOL index, the primary outcome, was constructed using items from Quality Of Life in Epilepsy Inventory
(QOLIE-31) and the Hospital Anxiety and Depression Scale (HADS) questionnaires. The internal consistency and
adequacy of these items was also computed using Cronbach's alpha and Kaiser-Meyer-Olkin tests. Partial correlations
were used to evaluate the contribution of the health dimensions (mental, psychological, social, physical functioning
and emotional well being) and, multiple linear regressions to determine factors independently associated with HRQOL.
Results: Just about half of the respondents (54%) were males, and nearly two thirds (62%) had received AEDs for at
least 12 months. The average age was 26.6 years (SD = 11.1). The overall HRQOL mean score was 58 (SD = 13) on a
scale of 0–100. The average scores of different dimensions or subscales ranged from 41 (physical) to 65 (psychological).
At least three quarters (75%) of all subscales had good internal consistency and adequacy. The largest variations in the
overall HRQOL were explained by social and mental functioning; each accounting for about 30% of the difference in
the HRQOL but seizure control features explained a little (6%) variation. Factors negatively associated with HRQOL were
poly-therapy (−1.16, p = 0.01) and frequency of seizures (−2.29, p = 0.00). Other factors associated with overall HRQOL
included drug side effects, sex, marital status and education. Duration on AEDs was not a significant predictor of HRQOL.
Conclusion: The HRQOL for epilepsy patients on AEDs is very low. The predictors of low HRQOL were socio factors
(marital status, education) and drug side effects, frequency of seizure, and type of therapy.
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The prevalence of epilepsy, a chronic disorder character-
ized by recurring seizures [1-3], is estimated to be 3% in
Uganda [4]. In addition to the unpredictable seizures, some
epileptic patients suffer with adverse effects of antiepileptic
drugs (AEDs), stigma, psychiatric co-morbidities, social or
physical limitations and the possibility of sudden unex-
pected death [1,5]. Epilepsy is associated with complex* Correspondence: anne1mulindwa@yahoo.com
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article, unless otherwise stated.effects on social, behavioral, physical, and psychological
wellbeing [1].
Whereas anti-epileptic drugs effectively control epi-
lepsy [3,6] in some patients, some AEDs fail while others
require poly-therapy (a combination of drugs) to en-
hance the seizure control [6,7]. The AEDs’ side effects,
especially for poly-therapies, have been shown to be
negatively associated with health-related quality of life
(HRQOL), independent of seizure frequency [8]. Indeed
other factors such as stigma [9], depression, anxiety andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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influence the quality of life of the patients with epilepsy
more than seizure severity and frequency control. For this
reason HRQOL has been suggested as the most reliable
approach for treatment and care of epilepsy. Quality of life
(QOL) addresses the different aspects of an individual’s
health status. However, in most developing countries such
as Uganda, epilepsy treatment has largely focused on re-
ducing seizures severity and frequencies as documented in
Uganda National Clinical Guidelines [12].
There are several studies that have evaluated relative
contributions of the physical, psychosocial functioning,
seizure-related factors and the qualities of life in patients
with epilepsy. Some of these studies have obtained con-
tradicting results about the role of these factors on
HRQOL. For example, Tracy et al. [13] found that de-
pression, and factors such as seizure control exert a
more limited effect on the HRQOL in epilepsy patients.
Bautista et al. [14] found a correlation between seizure
severity and HRQOL in people with epilepsy independ-
ent of seizure frequency, while Vickrey et al. [14] found
only minimal correlation between seizure severity and
the HRQOL of adult patients. Few studies have been
done in Sub-Saharan Africa even though majority of
patients with epilepsy (PWE) live there [3]. The HRQOL
scores depend on the cultural, ethnic and state of econ-
omy and therefore likely to vary from country to country
[6] and consequently results from elsewhere are less likely
to be generalisable to Ugandan population with epilepsy.
In this study, we estimated the HRQOL and assessed
the predictors of HRQOL outcomes in PWE receiving
antiepileptic drugs.Methods and materials
Study design and population
A cross-sectional study conducted in two mental clinics at
Mulago and Butabika national referral hospitals in Uganda
between May to July 2011. Mulago is the national referral
hospital and Butabika is the psychiatric national referral
hospital. The study population was all people aged 15 years
and above who had been on anti- epileptic treatment for
at least 3 months. We chose a cut off of 3 months with an
expectation that patients would have gotten a good experi-
ence on AEDs and possibly would knowledgeably describe
seizure control features. A sample size of 177 patients was
estimated for both hospitals combined and was calculated
to ensure that the overall HRQOL is estimated to within ±
3.25 error of the true HRQOL (on 0–100 scale) with 95%
Confidence interval, assuming non-response rate of 10%.
Using systematic sampling, with a sampling interval of 3,
patients were enrolled and interviewed on a daily basis
from Monday to Friday for a period of 4 weeks in each
hospital.Evaluation of HRQOL
HRQOL was measured using a combination of Quality
Of Life in Epilepsy (QOLIE)-31 and Hospital Anxiety
and Depression Scale (HADS) validated questionnaires.
Both tools were modified to suit the Ugandan situation
based on a manual by Guillemin (Guillemin et al., 1993),
translated into local languages before use. The QOLIE-
31 questionnaire contains 31 items that measure a patient’s
physical, social, mental functioning, emotional wellbeing
and seizure control features, while the HADS question-
naire includes items that measure anxiety and depression
(psychological functioning). Each question is scored on a
scale of 0 to 100, with 100 being the highest score. How-
ever, possible categories or response sets for scoring vary
across questions. Examples of response sets used include
(i) 0, 25, 50, 75, 100; ( ii) 0, 20, 40, 60, 80, 100; (iii) 0, 33,
67, 100. Questions on patient socio-demographics and
some clinical characteristics (such as partial or generalised
epilepsy type) were also included in the integrated ques-
tionnaire. Medical records were accessed to extract add-
itional information pertaining to the date of initiation of
AEDs and type of therapy (poly-therapy or mono-therapy).
Physical functioning was defined to encompass feel-
ings of fatigue or lack of energy to do activities of daily
living including taking care of personal hygiene, travel
and execution of job related tasks and explored using a
set of 7 questions. Socio-functioning (i.e. social limita-
tions or withdrawal and feelings of stigma) was mea-
sured using 6 questions aimed at assessing presence of
feelings of internalized stigma and the patient’s ability to
associate or relate with others. Emotional well-being was
assessed using 6 questions on the extent of worry over
epilepsy and seizure reoccurrence while the mental func-
tioning was based on question items that explored a pa-
tient’s ability to reason, memorise important aspects or
concentrate on key activities. Psychological functioning
was assessed using 11 questions (3 items related to
mood disturbances and 8 items related to anxiety and
depression). In constructing this psychological function-
ing score, a score for mood disturbance and score for
anxiety and depression were constructed separately bas-
ing on the HADS questionnaire manual. The two scores
were then combined with weights of 0.3 and 0.7 to re-
flect number of items in each. In all subscales, the higher
the scores, the better the quality of life but a score less
than 60 is considered poor. For seizure control features,
data were captured on the frequency and severity of sei-
zures and side effects of AEDs. The integrated question-
naire was administered by trained nurses with psychiatric
training hired from a private clinic but without links to
the two hospitals and technical support was given by the
Principal Investigator (AMN). In a limited number of
cases where a patient’s responses were not clear to some
questions, caretakers were asked to clarify further.
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Frequencies and percentages were used to summarise
the study sample characteristics including side effects of
AEDs, perceived impact of epilepsy on social life and
activities and feelings of stigma, among others. To deter-
mine the HRQOL of (PWE), the mean and median
scores of different items on the QOLIE-31 and HADS
questionnaire-based questions were used. The computa-
tion of HRQOL subscale scores (mental, social, physical,
psychological functioning as well as emotional well be-
ing) was based on the QOLIE-31 manual for summariz-
ing items using empirical derived weight. The internal
consistency and adequacy of such items were computed
using Cronbach's alpha [15] and Kaiser-Meyer-Olkin
(KMO) test [16].
Univariate linear regressions were done to assess
relationships between the overall HRQOL and each of
its subscales, seizure control features, sex, and other
demographic factors. Only factors that had an F statis-
tic p-value of 0.1 or less were included in the multiple
regression models. Multiple linear regressions were
used to assess relative importance of the different
factors (seizure control features, HRQOL subscales) on
HRQOL.
Similar linear regression analysis was done for each of
the subscales, mental, social, emotional, psychological,
and physical functioning. For statistical efficiency in the
final model, a multivariate regression was used. In this
model linear regression models for each subscale were
jointly fitted. The level of statistical significance was
determined at 5% and all analyses were done in STATA.Ethical approval
Ethical clearance was sought from the Makerere University
School of Public Health (MaKSPH) and High Degrees
Research and Ethics Committee (HDREC). Permission
was sought from both hospitals to interview as well as
access patients and their medical records. Consenting
adults of 18 years and above were enrolled into the study
and younger patients (15–17 years) provided assent and
consent was obtained from an adult caretaker.Results
Sample characteristics
A total of 175/ 177 (98%) patients participated. Two
patients declined the interviews. Of the 175 respondents,
54% were male; only 20% were employed and mainly in
the informal sector; 62% had been on AEDs for at least
12 months; 50% were aged below 25 years; 51% had
attained primary school education level at most; and
majority of the patients (77%) were never married. The
average age was 26.6 years (SD = 11.1). Majority of the
respondents (84%) had generalized epilepsy and about80% were on poly-therapy. The respondent socio-
demographic characteristics are detailed in Table 1.
Patients sampled from Butabika and Mulago hospitals
were different on some characteristics including age,
education level attained, duration of AEDs therapy and
type of therapy accessed (Table 1). For instance, 55% of
patients from Mulago were aged below 25 years as
compared to 51% from Butabika; 89% from Mulago ever
attended formal education as compared to only 63%
from Butabika hospital. Further, 8% and 53% of the pa-
tients sampled from Mulago hospital was on monother-
apy and been on AEDs from at least 12 months as
compared to only 37% and 75% from Butabika hospital,
respectively. Further analyses adjusted for hospital site.
Overall mean HRQOL and its subscales and drug side
effects
The overall HRQOL mean score was as low as 58 (SD = 13;
95% CI: 56–60) and a median of 58 (IQR: 47 – 68)
(Table 2). The averages of the different HRQOL subscale
scores ranged from 41 to 65, with physical functioning and
emotional well-being mean scores below 50. All the sub-
scales and overall HRQOL scores had a good internal
consistency and sampling adequacy (at least 75%) on the
questionnaire items used. Mood disturbance, anxiety and
depression are combined to form psychological functioning
subscale.
With respect to physical functioning, about 36% of the
respondents reported to have had trouble with public
transport because of their situation. Majority (85%) were
able to manage their personal hygiene. Similarly, about
54% are at least somewhat worried of occurrence of a
next seizure; with 60% embarrassed (or worried about
societal judgment) and about 70% more worried about
the seizure associated injuries. Using worries about em-
barrassment as a measure for `feelings of stigma’, over
60% respondents would be classified as having stigma.
Using seizure control as a proxy for best clinical out-
come, it was observed that there was a negative correl-
ation between seizure suppression and mental functioning
(Spearman’s r = −0.23; p-value = 0.071) i.e. patients whose
seizure control has not improved since initiating AEDs
had better mental functioning. Further, over 30% of re-
spondents reported that they had their memory and con-
centration affected shortly after taking the AEDS in the
past 4 weeks which is a known side effect. In general, 83%
patients reported that their quality of life had gotten better
after initiating AEDs but even so 61% rated their quality
of life to be below average.
HRQOL and relative importance of different factors and
subscales
From multiple linear regressions analysis; poly-therapy
and increased frequency of seizures are negatively and
Table 1 Demographics and clinical characteristics
Butabika Mulago Overall
Characteristic N (75) % (100) N (100) % (100) N (175) % (100)
Age group
15 – 19 23 30.7 24 24.0 47 26.9
20 – 24 23 30.7 30 30.0 53 30.3
25-29 8 10.7 21 21.0 29 16.6
30+ 21 28.0 25 25.0 46 20.3
Gender
Male 48 64.0 47 47.0 95 54.3
Female 27 36.0 53 53.0 80 45.7
Marital status
Married 8 10.7 14 14.0 22 12.6
Separated 4 5.3 14 14.0 18 10.3
Never married 63 84.0 72 72.0 135 77.1
Education level
None 12 16.0 11 11.0 23 13.1
Primary 32 42.7 35 35.0 67 38.3
Incomplete secondary 22 29.3 42 42.0 64 36.6
Complete secondary 9 12.0 12 12.0 21 12
*Epilepsy type
Generalized 70 93.3 76 76.8 146 83.9
Partial 5 6.7 23 23.2 28 16.1
Type of therapy
Mono therapy 28 37.3 8 8.0 36 20.6
Poly-therapy 47 62.7 92 92.0 139 79.4
Referral to hospital
H/worker 13 17.3 53 53.5 66 37.9
Self-referral 46 61.3 46 46.5 92 52.9
Other 16 21.3 0 0.0 16 9.2
Duration on treatment
3-12 months 19 25.3 47 47.0 66 37.7
More than 12 months 56 74.7 53 53.0 109 62.3
*For epilepsy type - data was missing for one participant.
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Both social functioning and mental functioning independ-
ently explained about 30% (partial correlations ≥ 0.33) of
the variation in the HRQOL. The extent of the effect of
seizure frequency is it plays a minor (6%) role but the wor-
ries about the seizure (and possibly stigma) as captured by
emotional well-being explained about 17% of the variation
in the overall HRQOL.
For socio-demographic factors; being female, married,
and having some formal education were significantly asso-
ciated with better HRQOL (Table 4). However, being on
poly-therapy, having AED side effects and high seizure fre-
quency were negatively associated with HRQOL. Similarly,patients in Mulago hospital had better HRQOL than those
from Butabika hospital. Being unmarried was signifi-
cantly associated with lower quality of life (t = −2.13;
p = 0.03) while age did not predict the overall HRQOL
(p-value = 0.41). Duration on AEDs was not significantly
associated with HRQOL. Marital status, education level,
poly-therapy, AEDs side effects and Site were significantly
associated with mental and social functioning. Poly-
therapy, AEDs side effects and Site are significant. On
the other hand, seizure frequency, hospital and AEDs
side effects were significantly associated with physical
and emotional wellbeing. For the psychological func-
tioning subscale, only seizure frequency and AEDs side
Table 2 Overall HRQOL and its subscale/components scores
General/Dimension Mean SD Min Max Median IQR Internal consistency Sampling adequacy
Overall HRQOL 58.1 13.1 28.1 85.4 57.7 21.6 0.75 0.77
HRQOL dimensions
Psychological functioning 64.8 17.0 20.0 97.5 65.0 23.4 0.78 0.76
Emotional well-being 48.6 31.2 0.0 100.0 44.3 45.0 0.90 0.87
Physical functioning 40.9 20.5 0.0 100.0 40.0 30.0 0.79 0.72
Mental functioning 59.5 20.1 15.8 91.7 58.3 34.0 0.87 0.84
Social functioning 61.1 25.2 5.0 100.0 58.0 42.0 0.75 0.77
Psychological items
Mood disturbance 62.2 18.9 20.0 100.0 65.0 25.0
Anxiety and depression 67.4 20.2 13.3 100.0 73.3 20.0
Medical side effects 66.5 27.3 0.0 100.0 66.7 33.3
Self-assessed QOL 61.7 20.4 25.0 100.0 75.0 25.0
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social and mental functioning were the same as those
of the overall HRQOL.
Discussion
In this study, we estimated the HRQOL score for People
with Epilepsy (PWE) in Uganda who had been on AEDs
for at least three months and also assessed the relative
importance of the different HRQOL sub-scores and as-
sociated predictors. This study showed that the HRQOL
mean score among the PWEs on AEDs in Uganda is
low, at 58 (on 0 – 100 scale). This low HRQOL score
implies that these PWEs have poor physical, psycho-
logical and mental functioning and poor emotional well-
being. Compared to the HRQOL subscales scores re-
ported among TB patients in Uganda in 2010 [17], the
PWEs have considerably lower HRQOL scores. Based on
a study by Babikako et al. [15], the social, physical and
mental functioning average scores for TB patients in
Uganda are estimated to be above 70. Similarly, the
HIV patients [18] in Uganda have above 80 average
score for physical and social functioning and theirTable 3 Multiple linear regression and partial correlations (R2
Variable Coef* SE
AED side effects −0.24 0.180
Therapy (Poly vs Mono) −1.16 0.466
Seizure frequency −2.29 0.505
Psychological functioning 0.18 0.014
Emotional well-being 0.08 0.007
Physical functioning 0.07 0.012
Mental functioning 0.27 0.012
Social functioning 0.22 0.009
Intercept 14.93 1.596
*Adjusted for hospital site.mental functioning score (average) is above 65. Re-
search in other countries has shown similarly low
HRQOL among the PWEs as compared to patients with
other chronic conditions [19-22]. In Italy and India, this
was attributed to low esteem and stigma and impact of
epilepsy on all dimensions of life.
Physical functioning and emotional well-being scores
are the most affected HRQOL domains despite PWEs
being on AEDs. This is likely because, despite reduced
seizure frequency, many physical activities are usually
restricted for fear of seizure occurrence. Further, over
60% of the patients could be classified as having stigma
(possibly internal stigma) which is expected among
PWEs as reported by Jacob [9]. This explains the poor
emotional well-being and highlights the fact that HRQOL
of PWEs has not improved.
Social, mental and psychological functioning play a
major role in contributing to the HRQOL in PWEs and
other patients with chronic conditions. The low scores
in this domain significantly depress the overall HRQOL.
For patients who are on treatment, such as in this study,
these domains are more important than seizure feature= 0.97) for overall HRQOL





























Age 0.11 0.33 0.06 −0.09 0.13 0.08
Sex (Female vs Male) 3.00 7.65 −3.77 4.77 6.68 4.34*
Marital status
Separated vs married −3.55 2.51 −0.81 −0.68 −8.27 −3.25
Not married vs married −1.84 −5.30 −2.00 −10.14* −10.74* −5.94*
Highest education level attained
Primary education vs none 3.15 −2.37 −4.59 10.04* 14.96* 6.14*
Incomplete secondary vs none 5.79 −4.44 −5.25 16.02* 25.02* 9.63*
Complete secondary vs none 2.45 −9.38 −4.44 10.24 26.07* 7.97*
Therapy (Mono vs Poly-therapy) 1.10 6.82 −5.77 5.44 8.38* 3.12*
Seizure frequency −6.31* −15.16* 7.48* 7.69* −3.68 −6.85*
AEDs side effects −3.56* −4.63* 4.65* −4.20* −3.53* −2.65*
Hospital site Butabika vs. Mulago −2.49 30.93* 13.56* 12.89* 14.19* 8.02*
Intercept 74.12 4.75 18.81 41.86 15.45 40.76
*Indicates significance at 5% level with tests carried on variables that have been transformed to normal distribution.
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frequency). This could be because even if seizure are
controlled it cannot necessary improve the social limita-
tions such as chances of marriage. Similarly, people who
are stigmatized might not adhere with the AEDs therapy
and hence might achieve limited seizure frequency
control. Thus, low social functioning and low emotional-
wellbeing are likely due to stigma arising from the pub-
lic, and some family members’ lack of knowledge about
epilepsy. This implies that without addressing these
other dimensions of HRQOL, the full benefits from
treatment with AEDs cannot be realized. In deed studies
elsewhere have also shown that treatment with AEDs
alone does not significantly improve the social and
psychological functioning of PWEs [23].
Mental functioning can actually be depressed for pa-
tients on poly-therapy as seen in this study and in other
studies elsewhere [7,24,25]. In other words, although
clinical management of seizures also aims to reduce on
AEDs’ side effects, it is evident that AEDs’ have an effect
on mental functioning of some patients and can poten-
tially depress their HRQOL. For example, in our study
patients on poly-therapy reported significantly higher
number of drug side effects, especially drowsiness, weak-
ness and feeling sleepy immediately after drug taking. This
is similar to study reported by Haag et al. [26]. Often poly-
therapy is associated with complex dosing regimens which
might be bothersome. Secondly, patients on poly-therapy
had lower seizure frequency but this was associated with
lower mental functioning. Livanainen et al. [27] in their
study reported that the continuous administration of some
AEDs highly controls seizures but was associated withmemory lapse, motor disorientation and aggressive behav-
ior. The implication of this is that a mere focus on seizure
control is not entirely beneficial to the overall quality of
life of the patient. Management of side effects related to
mental functioning will be key to improving the HRQOL
of the PWEs on AEDs in Uganda.
Being on AEDs improves HRQOL but the social and
mental functioning domains become predominantly import-
ant for overall improvement of HRQOL [21]. Low scores
for social functioning could be partly attributed to “feelings”
of stigma (using embarrassment as a proxy). It has been ob-
served in many studies among PWEs that stigma could lead
to psychopathology [28]. Since most the respondents in this
study reported embarrassment, it could explain why social
functioning played a key role in low HRQOL scores.
The other characteristics of the respondents that im-
pacted on their overall HRQOL positively included gen-
der, marital status and education level. However these
factors and seizure control features (seizure frequency
reduction, AEDs side effects) only explained 37% variation
in the overall HRQOL. This implies that other aspects of
overall HRQOL (e.g. social, mental, psychological func-
tioning, etc.) are more important to HRQOL once seizure
frequency is moderate. Being young was not substantially
associated with low HRQOL. Being married affords one
social and psychological support and hence reduces on
the negative impact of low scores of these aspects on
overall HRQOL. This also highlights the fact that once
psychologists and psychiatrists do not address the social,
psychological and mental functioning of PWE, family
members have to bear these burdens. Social support has
been found to be important in many studies [21].
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tions favorably and possibly handle stigma better. Other
studies have also reported the positive effect of educa-
tion [21]. This means helping the children with epilepsy
to get education can help to sustain their HRQOL
positively.
Limitations
The study recruited patients who were receiving treat-
ment from the two referral hospitals in Kampala, the
capital city. It could be that most of these patients hail
from the urban and semi-urban centres where QOL
might be better. In addition, because of their conditions,
sometimes the PWEs could not understand the ques-
tions asked, necessitating use of a caretaker to interpret
the questions for them and sometimes clarify on the
patients’ responses. There is a possibility that the care-
takers did not interpret the questions correctly which
might yield a wrong response. However, all the care-
takers were oriented on the meaning of the different
questions and their comprehension of the questions was
assessed. In addition, since the questions were adminis-
tered in Luganda (the local language) or English – the
official language in Uganda – it was possible for the
Principal Investigator to correct the caretaker’s interpret-
ation where the actual meaning was being missed by the
caretaker.
Conclusions
The HRQOL mean score of PWEs and receiving AEDs in
Uganda is very low (58). It is evident that current manage-
ment of epilepsy that focuses on only seizure control does
not improve HRQOL of the patients receiving AEDs.
Treatment of epilepsy should include other health dimen-
sions in addition to seizure control and AEDs side effects.
Adding clinical counseling and other interventions to
address the physical, mental, psychological, social and
emotional aspects for health wellbeing is likely to achieve
better health outcomes for epilepsy patients.
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